QuantiFERON试验在结核性葡萄膜炎诊断及抗结核治疗反应预测中的价值
这项单中心回顾性研究纳入2003年至2019年间接受QuantiFERON试验的1075例连续成人葡萄膜炎患者,其中178例(16.5%)阳性;62例(35%)按COTS标准诊断结核性葡萄膜炎并接受6个月抗结核治疗,44/62(71%)有治疗反应;QuantiFERON值>2 IU/mL与治疗反应几率更高相关(aOR=36.7,95%CI 7.2-185.9,p<0.001);诊断结核性葡萄膜炎兼顾灵敏度和特异度的最佳阈值为4 IU/mL。
要点
- 在非结核流行国家的大样本葡萄膜炎队列中,16.5%的患者QuantiFERON试验阳性。
- QuantiFERON值>2 IU/mL与抗结核治疗反应几率显著增高相关(aOR=36.7)。
- 诊断结核性葡萄膜炎兼顾灵敏度和特异度的最佳阈值为4 IU/mL。
核心结论
- 约六分之一葡萄膜炎患者QuantiFERON试验阳性。
- 诊断结核性葡萄膜炎兼顾灵敏度和特异度的最佳阈值为4 IU/mL。
- QuantiFERON值>2 IU/mL与抗结核治疗反应几率更高相关。
研究设计与样本
- 共纳入1075例患者,其中178例(16.5%)QuantiFERON试验阳性。
- 在178例阳性患者中,62例(35%)按更新版COTS分类诊断为结核性葡萄膜炎并接受6个月抗结核治疗。
主要发现
- 62例结核性葡萄膜炎患者中,44/62(71%)对抗结核治疗有反应。
- QuantiFERON值>2 IU/mL与抗结核治疗反应几率更高相关(aOR=36.7,95%CI 7.2至185.9,p<0.001)。
关键数值与推荐
- 诊断结核性葡萄膜炎兼顾灵敏度和特异度的最佳阈值为4 IU/mL。
- QuantiFERON值>2 IU/mL与抗结核治疗反应几率更高相关(aOR=36.7,95%CI 7.2至185.9,p<0.001)。
临床怎么用
- 对葡萄膜炎患者可考虑QuantiFERON试验辅助结核性葡萄膜炎诊断。
- QuantiFERON值>2 IU/mL可能提示抗结核治疗反应几率更高。
- 诊断结核性葡萄膜炎时QuantiFERON阈值4 IU/mL可兼顾灵敏度和特异度。
局限性
- 本研究为单中心回顾性研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Few studies have evaluated the contribution of QuantiFERON test for the diagnosis of tubercular uveitis in non-endemic countries for tuberculosis (TB). The objective of the present study was to evaluate the value of the QuantiFERON test in a large cohort of patients with uveitis for both the diagnosis of tubercular uveitis and antituberculosis treatment (ATT) response prediction. METHODS: A single-centre retrospective study including consecutive adult patients with uveitis who were prescribed a QuantiFERON test between January 2003 and December 2019 was performed. Adjusted ORs (aORs) were calculated between patients with uveitis responding and not responding to ATT according to the Collaborative Ocular Tuberculosis Study (COTS) group diagnostic criteria. Sensitivity (SE), specificity (Sp), and positive and negative predictive values of the QuantiFERON test were calculated. RESULTS: A total of 1075 patients were included in the study; 178 (16.5%) were found positive using the QuantiFERON test. Among the 178 positive patients, 62 (35%) had a diagnosis of tubercular uveitis according to the updated COTS classification; all received ATT for 6 months; and 44/62 (71%) responded to ATT. A QuantiFERON test value of >2 IU/mL was associated with a greater chance of responding to ATT (aOR=36.7, 95% CI 7.2 to 185.9, p<0.001). The optimal threshold to maximise both Sp and SE for diagnosis of TB uveitis was 4 IU/mL. CONCLUSION: One-sixth of the patients diagnosed with uveitis had a positive QuantiFERON test. The QuantiFERON threshold with the optimal SE and Sp for the diagnosis of tubercular uveitis was 4 IU/mL. TRIAL REGISTRATION NUMBER: NCT03863782.
引用
- Danjou W, Pradat P, Jamilloux Y, et al. Usefulness of the QuantiFERON test for the diagnosis of tubercular uveitis and the predictions of response to antituberculosis treatment. Br J Ophthalmol. 2021. PMID: 34711577. doi:10.1136/bjophthalmol-2021-318868
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。